Lu Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lu Zhang has a total of 180 co-authors. Here are the top co-authors by number of shared publications:
- Zhi Chen
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology Wuhan University Wuhan China
23 shared publications Lu Zhou
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, 430079, PR China
15 shared publications- Zhi-Jun Sun
The State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430079, China
14 shared publications Zhi Chen
The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan, China; Department of Endodontics, School and Hospital of Stomatology, Wuhan University, Wuhan, China
8 shared publicationsXiaolin Fang
Hubei‐MOST KLOS & KLOBM, School & Hospital of Stomatology Wuhan University Wuhan China
5 shared publicationsFei Pei
The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei‐MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology Wuhan University Wuhan China
4 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 65, 292-310
Pioneering next-generation bioactive materials for endodontics: Insights of mitochondrial biology
Endodontics, a vital discipline in dental medicine, focuses on pulp health preservation, disease treatment, and tissue regeneration, critically dependent on bioactive materials for therapeutic success. Conventional bioactive materials primarily focus on cellular-scale interactions, but with the advent of precision medicine, emerging evidence demonstrates that certain key organelles can influence disease progression by regulating cell fate. Mitochondria, beyond their energy-producing role, are central to cellular signaling, metabolic regulation, and inflammatory responses, profoundly impacting pulp cell survival, differentiation, and adaptation to pathological conditions such as hypoxia or inflammation. Therefore, this leading opinion paper synthesizes cutting-edge insights into mitochondrial biology and their implications for endodontics, proposing a shift in bioactive material design. Firstly, the pivotal roles of mitochondria in core cells relevant to endodontics is delinated. Subsequently, how existing endodontic materials impact mitochondria is described. Afterwards, the latest advances in mitochondria-based bioactive materials for endodontics are analyzed. Finally, the potential to pioneer next-generation endodontic bioactive materials through mitochondrial biology is explored. This paper aims to provide new possibilities for developing more advanced endodontic bioactive materials at the subcellular level.
- 1 November 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 65, 292-310
Open AccessPioneering next-generation bioactive materials for endodontics: Insights of mitochondrial biology
Endodontics, a vital discipline in dental medicine, focuses on pulp health preservation, disease treatment, and tissue regeneration, critically dependent on bioactive materials for therapeutic success. Conventional bioactive materials primarily focus on cellular-scale interactions, but with the advent of precision medicine, emerging evidence demonstrates that certain key organelles can influence disease progression by regulating cell fate. Mitochondria, beyond their energy-producing role, are central to cellular signaling, metabolic regulation, and inflammatory responses, profoundly impacting pulp cell survival, differentiation, and adaptation to pathological conditions such as hypoxia or inflammation. Therefore, this leading opinion paper synthesizes cutting-edge insights into mitochondrial biology and their implications for endodontics, proposing a shift in bioactive material design. Firstly, the pivotal roles of mitochondria in core cells relevant to endodontics is delinated. Subsequently, how existing endodontic materials impact mitochondria is described. Afterwards, the latest advances in mitochondria-based bioactive materials for endodontics are analyzed. Finally, the potential to pioneer next-generation endodontic bioactive materials through mitochondrial biology is explored. This paper aims to provide new possibilities for developing more advanced endodontic bioactive materials at the subcellular level.
- 20 May 2026
- Published by Elsevier in Translational Research
- Vol. 293, 29-43
Targeted protein degradation in inflammatory bone diseases: Mechanistic basis and therapeutic opportunities
- 20 May 2026
- Published by Elsevier in Translational Research
- Vol. 293, 29-43
Targeted protein degradation in inflammatory bone diseases: Mechanistic basis and therapeutic opportunities
- 21 March 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 695, 126793
mRNA therapeutics for inflammatory bone diseases: opportunity and challenge
- 21 March 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 695, 126793
mRNA therapeutics for inflammatory bone diseases: opportunity and challenge
- Open Access
- 3 February 2026
- Published by Springer Nature in International Journal of Oral Science
- Vol. 18 (1) , 13
Cuproptosis promotes inflammatory osteolysis via GYS1-mediated glycogen metabolism
Copper, predominantly present in bones, plays a crucial role in bone formation. However, when copper homeostasis is disrupted, excessive copper can trigger harmful inflammation and a novel form of cell death known as cuproptosis. The impact of cuproptosis on bone metabolism remains unclear. In this study, we demonstrated that excessive copper acts as an aggravator in osteoclastogenesis and bone resorption. We observed that the expression levels of the copper importer SLC31A1 and dihydrolipoamide S-acetyltransferase (DLAT) were positively correlated with bone loss in both human chronic apical periodontitis (CAP) tissues and mouse CAP models. Untargeted metabolomics analysis and screening of glucose metabolism enzymes revealed that glycogen synthesis was inhibited during cuproptosis. Mechanistically, excessive copper hindered glycogen synthesis via glycogen synthase 1 (GYS1), which limited the availability of glycogenolysis-derived glucose-6-phosphate (G6P) flux into pentose phosphate pathway (PPP), and was unable to yield abundant NADPH to ensure high demand of glutathione (GSH) for macrophage survival. The inhibition of glycogen synthesis intensified cuproptosis and bone-resorption activity. Moreover, excessive copper bound to H3K27me3, which further epigenetically inhibited the gene transcription of GYS1, thereby affecting glycogen synthesis and exacerbating cuproptosis and bone resorption. Furthermore, the disruption of glycogen metabolism intensified cuproptosis and promoted inflammatory bone loss in vivo. Our finding highlighted the complex interplay among copper homeostasis, glycogen metabolism, and the osteo-immune system, suggesting new therapeutic strategies for managing inflammatory bone diseases and other copper accumulation-related conditions through the metabolic reprogramming of cells.
- 3 February 2026
- Published by Springer Nature in International Journal of Oral Science
- Vol. 18 (1) , 13
Open AccessCuproptosis promotes inflammatory osteolysis via GYS1-mediated glycogen metabolism
Copper, predominantly present in bones, plays a crucial role in bone formation. However, when copper homeostasis is disrupted, excessive copper can trigger harmful inflammation and a novel form of cell death known as cuproptosis. The impact of cuproptosis on bone metabolism remains unclear. In this study, we demonstrated that excessive copper acts as an aggravator in osteoclastogenesis and bone resorption. We observed that the expression levels of the copper importer SLC31A1 and dihydrolipoamide S-acetyltransferase (DLAT) were positively correlated with bone loss in both human chronic apical periodontitis (CAP) tissues and mouse CAP models. Untargeted metabolomics analysis and screening of glucose metabolism enzymes revealed that glycogen synthesis was inhibited during cuproptosis. Mechanistically, excessive copper hindered glycogen synthesis via glycogen synthase 1 (GYS1), which limited the availability of glycogenolysis-derived glucose-6-phosphate (G6P) flux into pentose phosphate pathway (PPP), and was unable to yield abundant NADPH to ensure high demand of glutathione (GSH) for macrophage survival. The inhibition of glycogen synthesis intensified cuproptosis and bone-resorption activity. Moreover, excessive copper bound to H3K27me3, which further epigenetically inhibited the gene transcription of GYS1, thereby affecting glycogen synthesis and exacerbating cuproptosis and bone resorption. Furthermore, the disruption of glycogen metabolism intensified cuproptosis and promoted inflammatory bone loss in vivo. Our finding highlighted the complex interplay among copper homeostasis, glycogen metabolism, and the osteo-immune system, suggesting new therapeutic strategies for managing inflammatory bone diseases and other copper accumulation-related conditions through the metabolic reprogramming of cells.
- 20 November 2025
- Published by Elsevier in Biochemical Pharmacology
- Vol. 243 (Pt 2) , 117541
The role of metabolic reprogramming in inflammatory bone diseases
- 20 November 2025
- Published by Elsevier in Biochemical Pharmacology
- Vol. 243 (Pt 2) , 117541
The role of metabolic reprogramming in inflammatory bone diseases
- Open Access
- 8 November 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 1-5
Correction: Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma
- 8 November 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 1-5
Open AccessCorrection: Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma
- Open Access
- 1 November 2025
- Published by Tsinghua University Press in Nano Research
- Vol. 18 (11)
Neutrophil hitchhiking delivers STING antagonist alleviating inflammatory osteolysis
Inflammatory cascade critically exacerbates pathological bone loss, however whether aberrant STING activation is involved has not been clarified. Utilizing STING as a target to alleviate inflammatory osteolysis is worth exploring. Herein, we identified hyperactivated STING signaling as a key driver in the pathogenesis of calvarial osteolysis, suggesting that local inhibition of STING alleviated inflammation-mediated bone loss. A pivotal unmet need lies in achieving rapid organ-specific drug delivery with minimized dosage across anatomically distinct inflammatory bone compartments. We engineered neutrophils (NEs) encapsulated with poly (lactic-co-glycolic acid) (PLGA) containing STING antagonist C176 (C176/PLGA@NEs) that leveraged the innate chemotactic proficiency of bone marrow-derived NEs for inflammatory site navigation. The inflammatory transport capacity of live NEs effectively addressed challenges of high systemic doses faced by STING antagonist, and poor spatiotemporal precision in targeting osteolytic lesions. The bioengineered C176/PLGA@NEs exhibited superior biocompatibility, inflammatory chemotaxis and inflammation-responsive release, and were effective in inhibiting STING-NF-κB pathway and remodeling macrophage polarization in vitro. In both calvarial osteolysis and apical periodontitis models, intravenous C176/PLGA@NEs administration achieved greater bone preservation compared to free C176 at equivalent doses, accompanied by reduction in pro-inflammatory cytokines. Notably, this NE-enabled strategy demonstrated targeting efficiency, overcoming anatomical barriers. Our findings establish a paradigm for precision delivery of STING antagonists using endogenous immune vectors, offering a versatile platform to treat systemic inflammatory bone disorders. The integration of cellular tropism with stimuli-responsive nanocarriers opens avenues for adapting this biohybrid approach to other immune cells and inflammatory pathologies.
- 1 November 2025
- Published by Tsinghua University Press in Nano Research
- Vol. 18 (11)
Open AccessNeutrophil hitchhiking delivers STING antagonist alleviating inflammatory osteolysis
Inflammatory cascade critically exacerbates pathological bone loss, however whether aberrant STING activation is involved has not been clarified. Utilizing STING as a target to alleviate inflammatory osteolysis is worth exploring. Herein, we identified hyperactivated STING signaling as a key driver in the pathogenesis of calvarial osteolysis, suggesting that local inhibition of STING alleviated inflammation-mediated bone loss. A pivotal unmet need lies in achieving rapid organ-specific drug delivery with minimized dosage across anatomically distinct inflammatory bone compartments. We engineered neutrophils (NEs) encapsulated with poly (lactic-co-glycolic acid) (PLGA) containing STING antagonist C176 (C176/PLGA@NEs) that leveraged the innate chemotactic proficiency of bone marrow-derived NEs for inflammatory site navigation. The inflammatory transport capacity of live NEs effectively addressed challenges of high systemic doses faced by STING antagonist, and poor spatiotemporal precision in targeting osteolytic lesions. The bioengineered C176/PLGA@NEs exhibited superior biocompatibility, inflammatory chemotaxis and inflammation-responsive release, and were effective in inhibiting STING-NF-κB pathway and remodeling macrophage polarization in vitro. In both calvarial osteolysis and apical periodontitis models, intravenous C176/PLGA@NEs administration achieved greater bone preservation compared to free C176 at equivalent doses, accompanied by reduction in pro-inflammatory cytokines. Notably, this NE-enabled strategy demonstrated targeting efficiency, overcoming anatomical barriers. Our findings establish a paradigm for precision delivery of STING antagonists using endogenous immune vectors, offering a versatile platform to treat systemic inflammatory bone disorders. The integration of cellular tropism with stimuli-responsive nanocarriers opens avenues for adapting this biohybrid approach to other immune cells and inflammatory pathologies.
- 5 June 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 161, 114987
The interplay between STING and metabolic reprogramming: From mechanisms to therapeutic strategies
- 5 June 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 161, 114987
The interplay between STING and metabolic reprogramming: From mechanisms to therapeutic strategies
- 14 February 2025
- Published by SAGE Publications in Journal of Dental Research
- Vol. 104 (5) , 541-550
Cuproptosis Aggravates Pulpitis by Inhibiting the Pentose Phosphate Pathway
Excessive copper becomes toxic, driving inflammation, and, when copper exceeds a certain threshold, it even leads to a novel programmed cell death termed cuproptosis . However, disordered copper metabolism and its mechanism in pulpitis remain unclear. In this work, we found that lipoteichoic acid (LTA) or lipopolysaccharides (LPS) triggered copper deposition in pulpitis and consequently intensified cuproptosis by impeding the pentose phosphate pathway (PPP). We initially assessed the copper content in pulpitis tissues via inductively coupled plasma mass spectrometry and observed significantly greater concentrations than in healthy pulp tissues. We found that a relatively high copper content was triggered by LTA or LPS, leading cells to cuproptosis. Stimulation of LTA or LPS induced copper deposition and cuproptosis, worsening the progression of pulpitis in vivo. Mechanistically, we found that copper detoxification is dependent on the PPP. We used a 13 C-glucose stable isotope-tracing experiment to assess the effect of glucose utilization on cuproptosis. Excessive copper hindered the PPP, resulting in an inadequate generation of nicotinamide adenine dinucleotide phosphate to replenish glutathione and counteract copper toxicity. The PPP regulates the phenotype, function, and survival of preodontoblast-like cells in cuproptosis. Our findings revealed the intricate interplay among bacteria, copper homeostasis, and metabolic reprogramming, providing potential strategies for host-targeted therapy in pulpitis.
- 14 February 2025
- Published by SAGE Publications in Journal of Dental Research
- Vol. 104 (5) , 541-550
Cuproptosis Aggravates Pulpitis by Inhibiting the Pentose Phosphate Pathway
Excessive copper becomes toxic, driving inflammation, and, when copper exceeds a certain threshold, it even leads to a novel programmed cell death termed cuproptosis . However, disordered copper metabolism and its mechanism in pulpitis remain unclear. In this work, we found that lipoteichoic acid (LTA) or lipopolysaccharides (LPS) triggered copper deposition in pulpitis and consequently intensified cuproptosis by impeding the pentose phosphate pathway (PPP). We initially assessed the copper content in pulpitis tissues via inductively coupled plasma mass spectrometry and observed significantly greater concentrations than in healthy pulp tissues. We found that a relatively high copper content was triggered by LTA or LPS, leading cells to cuproptosis. Stimulation of LTA or LPS induced copper deposition and cuproptosis, worsening the progression of pulpitis in vivo. Mechanistically, we found that copper detoxification is dependent on the PPP. We used a 13 C-glucose stable isotope-tracing experiment to assess the effect of glucose utilization on cuproptosis. Excessive copper hindered the PPP, resulting in an inadequate generation of nicotinamide adenine dinucleotide phosphate to replenish glutathione and counteract copper toxicity. The PPP regulates the phenotype, function, and survival of preodontoblast-like cells in cuproptosis. Our findings revealed the intricate interplay among bacteria, copper homeostasis, and metabolic reprogramming, providing potential strategies for host-targeted therapy in pulpitis.
- 11 February 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 195, 225-239
Mitochondria-loading erythrocytes transfer mitochondria to ameliorate inflammatory bone loss
- 11 February 2025
- Published by Elsevier in Acta Biomaterialia
- Vol. 195, 225-239
Mitochondria-loading erythrocytes transfer mitochondria to ameliorate inflammatory bone loss